WM ResourcesWM Resources

WM Resources

Stay Informed. Stay Motivated. Stay Connected. 

Resources and support for patients with WM

Surround yourself with support

As you move through your treatment journey with IMBRUVICA® (ibrutinib), always keep in touch with your healthcare team and don’t hesitate to ask questions. Your doctors, nurses, and pharmacists all bring specific types of expertise to your care and are ready to answer questions and provide you with support and Waldenström's macroglobulinemia (WM) resources.

You are also part of a wider support community

  • Relationships with family and friends can provide valuable support. Don’t be afraid to turn to them for support
  • More formal support groups are also available where you can meet other adults living with WM or other cancers. Your doctor and treatment facility should be able to provide you with contacts to groups in your area
  • Additionally you can enroll in the IMBRUVICA® By Your Side patient support program, which is a personalized program that helps you learn about access to IMBRUVICA® (ibrutinib), find affordability support options, and sign up for information and resources to support you along your treatment journey

Have questions about IMBRUVICA®?

From cost and coverage options to Ambassador support - we're here to help.

Learn More

Stay informed and motivated

Knowledge is empowering—so try to learn all you can about your condition. The websites below are good places to find additional information on WM, treatment options, support groups, and resources.

For more information on WM:

For cancer support communities:

Pharmacyclics, an AbbVie Company, may collect your personal data through your online and offline interactions with us, including your contact, demographic, geolocation, and health-related data. We may also collect your online usage data automatically through cookies and similar technologies. We use this data for several purposes, such as to provide you with and improve our programs, services, and products, customize your experiences, and for research and analytics. We retain your personal data for as long as necessary to fulfill these purposes or to comply with our record retention obligations. We do not sell your personal data but may use and disclose your personal data with marketing and advertising partners to deliver you ads based on your interests inferred from your activity across other unaffiliated sites and services (“online targeted advertising”) and for website analytics. To opt out of the use or disclosure of your personal data for online targeted advertising or for website analytics, go to Your Privacy Choices on our website. For more information on the personal data categories we collect, the purposes for their collection, our disclosures to third parties, your data subject rights, and our data retention criteria, visit our Privacy Notice.

Through my submission of the program enrollment form, I consent to the collection, use, and disclosure of my personal health data, as described in the Privacy Notice above and in AbbVie’s Privacy Notice in the How We May Disclose Personal Data section. My consent is required to process sensitive personal data under certain privacy laws, and I have the right to withdraw my consent by visiting Your Privacy Choices on AbbVie’s website.

IMBRUVICA® (ibrutinib) is covered by U.S. Patents, which are listed in FDA's Orange Book (available at